Barbora Peltanová
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Otorhinolaryngology top 10%
Papers in
-
- Cancer, Hypoxia, and Metabolism 4
- MicroRNA in disease regulation 1
- Oncology 3
- Cancer Cells and Metastasis 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Martina Raudenská (6 shared papers)Michal Masařík (6 shared papers)Hana Polanská (4 shared papers)Jiří Navrátil (3 shared papers)Jaromír Gumulec (2 shared papers)Michal Staník (1 shared paper)Jan Plzák (2 shared papers)Dalibor Pacík (1 shared paper)
- Journals
- Cancers (1 paper)Scientific Reports (1 paper)International Journal of Molecular Sciences (1 paper)Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (1 paper)Molecular Cancer (1 paper)
- Partner nations
- CzechiaNetherlandsGermany
In The Last Decade
Barbora Peltanová
7 papers receiving 440 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 157
- Otorhinolaryngology 36
- Oncology 197
- Immunology 113
- Molecular Biology 228
Countries citing papers authored by Barbora Peltanová
This map shows the geographic impact of Barbora Peltanová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbora Peltanová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbora Peltanová more than expected).
Fields of papers citing papers by Barbora Peltanová
This network shows the impact of papers produced by Barbora Peltanová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbora Peltanová. The network helps show where Barbora Peltanová may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbora Peltanová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 316 | |
| 2 | 2022 | 54 | |
| 3 | 2018 | 34 | |
| 4 | 2021 | 23 | |
| 5 | 2021 | 9 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 2 | |
| 8 | 2026 | 0 |
About Barbora Peltanová
Barbora Peltanová is a scholar working on Cancer Research, Oncology, Molecular Biology, Surgery and Urology, having authored 8 papers that have together received 446 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (3 papers), Cancer-related Molecular Pathways (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), MicroRNA in disease regulation (1 paper), Graphene and Nanomaterials Applications (1 paper), Nanoplatforms for cancer theranostics (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Cancer Research (157 citations), Otorhinolaryngology (36 citations), Oncology (197 citations), Immunology (113 citations) and Molecular Biology (228 citations). Barbora Peltanová has collaborated with scholars based in Czechia, Netherlands and Germany. Frequent co-authors include Martina Raudenská, Michal Masařík, Hana Polanská, Jiří Navrátil, Jaromír Gumulec, Michal Staník, Jan Plzák, Dalibor Pacík, Michal Fedorko and Marek Grega. Their work appears in journals such as Cancers, Scientific Reports, International Journal of Molecular Sciences, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.